Oakworth Capital’s Quest Diagnostics DGX Stock Holding History

Oakworth Capital’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.6K	Hold	50	–	–	﹤0.01%	691
2026 Q1	$9.8K	Hold	50	–	–	﹤0.01%	660
2025 Q4	$8.68K	Hold	50	–	–	﹤0.01%	673
2025 Q3	$9.53K	Hold	50	–	–	﹤0.01%	633
2025 Q2	$8.98K	Hold	50	–	–	﹤0.01%	498
2025 Q1	$8.46K	Hold	50	–	–	﹤0.01%	530
2024 Q4	$7.54K	Sell	50 -33	-40%	-$5.13K	﹤0.01%	519
2024 Q3	$12.9K	Hold	83	–	–	﹤0.01%	487
2024 Q2	$11.4K	Hold	83	–	–	﹤0.01%	476
2024 Q1	$11K	Hold	83	–	–	﹤0.01%	467
2023 Q4	$11.4K	Hold	83	–	–	﹤0.01%	461
2023 Q3	$10.1K	Hold	83	–	–	﹤0.01%	445
2023 Q2	$11.7K	Hold	83	–	–	﹤0.01%	443
2023 Q1	$11.7K	Hold	83	–	–	﹤0.01%	422
2022 Q4	$13K	Hold	83	–	–	﹤0.01%	391
2022 Q3	$10K	Hold	83	–	–	﹤0.01%	445
2022 Q2	$11K	Hold	83	–	–	﹤0.01%	430
2022 Q1	$11K	Hold	83	–	–	﹤0.01%	438
2021 Q4	$14K	Sell	83 -17	-17%	-$2.59K	﹤0.01%	455
2021 Q3	$15K	Sell	100 -100	-50%	-$14.6K	﹤0.01%	435
2021 Q2	$26K	Sell	200 -184	-48%	-$24.1K	﹤0.01%	387
2021 Q1	$49K	Hold	384	–	–	0.01%	308
2020 Q4	$46K	Hold	384	–	–	0.01%	291
2020 Q3	$44K	Sell	384 -9	-2%	-$1.06K	0.01%	289
2020 Q2	$45K	Hold	393	–	–	0.01%	283
2020 Q1	$32K	Hold	393	–	–	0.01%	288
2019 Q4	$41K	Hold	393	–	–	0.01%	306
2019 Q3	$42K	Sell	393 -1,695	-81%	-$174K	0.01%	308
2019 Q2	$212K	Hold	2,088	–	–	0.04%	163
2019 Q1	$187K	Sell	2,088 -230	-10%	-$19.9K	0.04%	178
2018 Q4	$193K	Sell	2,318 -290	-11%	-$27.2K	0.04%	157
2018 Q3	$281K	Hold	2,608	–	–	0.06%	140
2018 Q2	$286K	Hold	2,608	–	–	0.06%	130
2018 Q1	$264K	Hold	2,608	–	–	0.06%	132
2017 Q4	$257K	Hold	2,608	–	–	0.06%	133
2017 Q3	$283K	Hold	2,608	–	–	0.07%	123
2017 Q2	$290K	Hold	2,608	–	–	0.08%	114
2017 Q1	$257K	Hold	2,608	–	–	0.07%	128
2016 Q4	$228K	Hold	2,608	–	–	0.08%	138
2016 Q3	$221K	Hold	2,608	–	–	0.08%	133
2016 Q2	$201K	Buy	2,608 +1,594	+157%	+$121K	0.08%	139
2016 Q1	$72K	Buy	1,014 +750	+284%	+$50.3K	0.03%	184
2015 Q4	$19K	Hold	264	–	–	0.01%	299
2015 Q3	$16K	Hold	264	–	–	0.01%	264
2015 Q2	$19K	Sell	264 -2,000	-88%	-$148K	0.01%	260
2015 Q1	$162K	Hold	2,264	–	–	0.07%	125
2014 Q4	$152K	Buy	2,264 +2,000	+758%	+$126K	0.08%	128
2014 Q3	$17K	Hold	264	–	–	0.01%	244
2014 Q2	$15K	Hold	264	–	–	0.01%	255
2014 Q1	$15K	Hold	264	–	–	0.01%	251
2013 Q4	$14K	Buy	+264	New	+$15.7K	0.01%	238

Other funds holding DGX

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

CPC

Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return

AIM

Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

SIC

Schwartz Investment Counsel Plymouth, Michigan $3.01B AUM 27.22% 1-Year Est. Return

BCAM

Boston Common Asset Management Boston, Massachusetts $1.69B AUM 28.29% 1-Year Est. Return

Oakworth Capital's DGX Position: Q2 2026 in Review

Oakworth Capital held its Quest Diagnostics (DGX) position steady in Q2 2026 at 50 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #691.

Oakworth Capital first reported a position in DGX in Q4 2013 and has held it in 51 quarters since. The position peaked at $290K in Q2 2017. 297 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Oakworth Capital held 50 shares of Quest Diagnostics worth $10.6K as of Q2 2026.
Oakworth Capital left its Quest Diagnostics share count unchanged in Q2 2026.
Quest Diagnostics made up ﹤0.01% of Oakworth Capital's portfolio in Q2 2026, its #691 holding.
Oakworth Capital first reported a position in Quest Diagnostics in Q4 2013 and has held it in 51 quarters since.
Oakworth Capital's Quest Diagnostics position peaked at $290K in Q2 2017.
297 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Oakworth Capital's 13F filing for Q2 2026, filed 22 Jul 2026.